| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 1308 | 180 | 172 | 18 |
Internal medicine, Pharmacology, Chemotherapy, Pharmacokinetics and Oncology are among the topics commonly tackled in the journal. The concepts on Internal medicine presented in the journal can also apply to other research fields, including Gastroenterology, Endocrinology and Surgery. Some problems in Gastroenterology that were presented in the journal overlapped with concepts under Nausea, Vomiting, Adverse effect and Neutropenia.
Cancer Chemotherapy and Pharmacology explores topics in Pharmacology which can be helpful for research in disciplines like In vitro, Toxicity, In vivo and Doxorubicin. It focuses on In vitro but sometimes tackles the closely related topic of Cell culture which is concerned with Molecular biology. The journal explores issues in Chemotherapy which can be linked to other research areas like Regimen and Urology.
The journal holds forums on Pharmacokinetics that merges themes from other disciplines such as Oral administration, Blood plasma and Metabolite. Oncology research featured in the journal incorporates concerns from various other topics such as Gemcitabine, Breast cancer, Clinical trial and Docetaxel. The close relationship between Cancer research and Pathology, Cell growth and Cancer cell is one of the points of interest dissected in Cancer research.
The journal publications focus on Pharmacology, Internal medicine, Chemotherapy, Pharmacokinetics and Cancer research. While the most cited articles focused on Pharmacology, they were also able to explore topics like Cisplatin, Paclitaxel, Doxorubicin, Toxicity and In vivo. In addition to Internal medicine research, the published papers aim to explore topics under Gastroenterology, Endocrinology, Surgery and Oncology.
The aim of the journal is to expand the discussion of research in Internal medicine, Pharmacokinetics, Oncology, Cancer research and Chemotherapy. Cancer Chemotherapy and Pharmacology dives deep in exploring the relationship between the study of Internal medicine and Gastroenterology. Pharmacokinetics studies covered in Cancer Chemotherapy and Pharmacology falls within the purview of Pharmacology.
The journal facilitates discussions on Pharmacology that incorporate concepts from other fields like CYP3A4 and CYP3A. Cancer research research presented in it encompasses a variety of subjects, including Apoptosis, Protein kinase B, Cancer cell, Downregulation and upregulation and In vivo. Cancer Chemotherapy and Pharmacology tackles studies in Breast cancer and the interrelated subject of Cyclophosphamide to gain insights into Chemotherapy.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Cancer Chemotherapy and Pharmacology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Cancer Chemotherapy and Pharmacology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 4.92% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 9.77% were posted by at least one author from the top 10 institutions publishing in the journal. Another 9.77% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 14.37% of all publications and 66.09% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Another excellent resource to consider for those looking to pursue a career in Oncology, especially within Iowa, is exploring the top Nurse Practitioner (NP) programs available. The advanced training provided by these postgraduate programs can foster a deep understanding of cancer chemotherapy and pharmacology, greatly enhancing a researcher's contributions to oncology. Program focuses typically include areas such as Internal Medicine, Pharmacology, and Pharmacokinetics, aligning closely with the research topics frequently explored within the journal. The best NP programs in Iowa can equip researchers with a robust and unique skill set which can drive innovative and practical advancements in cancer chemotherapy and pharmacological practices. These programs often feature specially tailored courses that delve into topics such as Gastroenterology, Endocrinology, and Surgery, which set the stage for understanding and advancing cancer patient care and treatment efficacy. Developing competency in these areas empowers researchers to extend their scholarly contributions beyond traditional topics, fostering significant innovation and progress within the sphere of cancer research.
Anne Schett;Sacha I Rothschild;Alessandra Curioni-Fontecedro;Stephan Krähenbühl
(2020)Anthony W. Tolcher;Razelle Kurzrock;Vincente Valero;Rene Gonzalez
(2020)Takashi Higuchi;Takashi Higuchi;Norihiko Sugisawa;Jun Yamamoto;Hiromichi Oshiro
(2020)Sanne C F A Huijberts;Robin M J M van Geel;Robin M J M van Geel;Robin M J M van Geel;Emilie M J van Brummelen;Frans L Opdam
(2020)Akihito Kawazoe;Yasutoshi Kuboki;Hideaki Bando;Shota Fukuoka
(2020)Fred Saad;Kim N. Chi;Neal D. Shore;Julie N. Graff
(2021)Emily Greengard;Yael P. Mosse;Xiaowei Liu;Charles G. Minard
(2020)Filipa Lynce;James T. Williams;James T. Williams;Meredith M. Regan;Craig A. Bunnell
(2021)Exploring Medicine in the USA opens doors to various related online degrees and career pathways that complement or offer alternatives within healthcare. For those interested in advancing nursing careers, understanding dnp psychiatric nurse practitioner salary provides valuable insight into potential earnings and job outlook across states.
Many aspiring nurse practitioners wonder how many years to become a nurse practitioner are required. Accelerated online programs often allow completion within a few years, fast-tracking career advancement while balancing other commitments.
For registered nurses looking to elevate their qualifications, enrolling in an rn to bsn online program can be an efficient step. These programs offer flexibility and can significantly enhance clinical and leadership skills necessary for expanded responsibilities.
Additionally, transitioning from an associate degree in nursing to a family nurse practitioner is possible through asn to fnp programs. Such bridges provide streamlined paths to graduate-level credentials, increasing job opportunities and specialized practice options.
